Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

53 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Clinical and Demographic Characteristics of Patients with Coexistent Hypertension, Type 2 Diabetes Mellitus, and Dyslipidemia: A Retrospective Study from India.
Dalal J, Chandra P, Chawla R, Kumar V, Abdullakutty J, Natarajan V, Naqvi SMH, Gaurav K, Rathod R, Dhanaki G, Kotak B, Shah S. Dalal J, et al. Among authors: abdullakutty j. Drugs Real World Outcomes. 2024 Mar;11(1):167-176. doi: 10.1007/s40801-023-00400-3. Epub 2023 Dec 1. Drugs Real World Outcomes. 2024. PMID: 38038836 Free PMC article.
Impact of real-time optical coherence tomography and angiographic coregistration on the percutaneous coronary intervention strategy.
Kadavil RM, Abdullakutty J, Patel T, Rathnavel S, Singh B, Chouhan NS, Malik FTN, Hiremath S, Gunasekaran S, Kalarickal SM, Kumar V, Subban V. Kadavil RM, et al. Among authors: abdullakutty j. AsiaIntervention. 2023 Sep 21;9(2):124-132. doi: 10.4244/AIJ-D-22-00064. eCollection 2023 Sep. AsiaIntervention. 2023. PMID: 37736205 Free PMC article.
Torsemide in the Management of Essential Hypertension.
Bhattacharyya K, Tiwaskar M, Datta A, Chandani AL, Agrawal SK, Abdullakutty J, Badani R, Doshi D, Singh V, Advani P, Varghese K, Pandey AK, Francis F, Sugumaran A. Bhattacharyya K, et al. Among authors: abdullakutty j. J Assoc Physicians India. 2024 Sep;72(9S):35-37. doi: 10.59556/japi.72.0676. J Assoc Physicians India. 2024. PMID: 39291572 Review.
Indian Consensus on the Role and Position of Angiotensin Receptor-neprilysin Inhibitors in the Management of Heart Failure.
Chopra HK, Ponde C, Wander GS, Nair T, Ray S, Khullar D, Nanda NC, Narula J, Kasliwal RR, Rana DS, Kirpalani A, Sawhney JS, Chandra P, Mehta Y, Kumar V, Tiwari S, Pancholia AK, Kher V, Bansal S, Mittal S, Kerkar P, Sahoo PK, Hotchandani R, Prakash S, Chauhan N, Rastogi V, Abdullakutty J, Shanmugasundaram S, Tiwaskar M, Sinha A, Gupta V, Mishra SS, Routray SN, Omar AK, Swami OC, Jaswal A, Alam S, Passey R, Rajput R, Paul J, Kapoor A, Dorairaj P, Chandra S, Malhotra P, Singh VP, Bansal M, Jain S, Shah P, Bhargava M, Vijayalakshmi IB, Varghaese K, Jain D, Goel A, Mahmood K, Gaur N, Tandon R, Moorthy A, George S, Katyal VK, Mantri RR, Mehrotra R, Bhalla D, Mittal V, Rao S, Jagia M, Singh H, Awasthi S, Sattur A, Mishra R, Pandey A, Chawla R, Jaggi S, Sehgal B, Sehgal A, Goel N, Gupta R, Kubba S, Chhabra A, Bagga S, Shastry RN. Chopra HK, et al. Among authors: abdullakutty j. J Assoc Physicians India. 2024 Sep;72(9):75-82. doi: 10.59556/japi.72.0664. J Assoc Physicians India. 2024. PMID: 39291524
Asundexian versus Apixaban in Patients with Atrial Fibrillation.
Piccini JP, Patel MR, Steffel J, Ferdinand K, Van Gelder IC, Russo AM, Ma CS, Goodman SG, Oldgren J, Hammett C, Lopes RD, Akao M, De Caterina R, Kirchhof P, Gorog DA, Hemels M, Rienstra M, Jones WS, Harrington J, Lip GYH, Ellis SJ, Rockhold FW, Neumann C, Alexander JH, Viethen T, Hung J, Coppolecchia R, Mundl H, Caso V; OCEANIC-AF Steering Committee and Investigators. Piccini JP, et al. N Engl J Med. 2025 Jan 2;392(1):23-32. doi: 10.1056/NEJMoa2407105. Epub 2024 Sep 1. N Engl J Med. 2025. PMID: 39225267 Clinical Trial.
The Promise of Cilnidipine in Hypertension with Comorbidities: National Consensus Statement: National Consensus Group Comprises Cardiologists, Nephrologists, and Diabetologists from India in a National Meet at New Delhi held on 22nd May 2022.
Chopra HK, Wander GS, Ponde CK, Nanda NC, Khullar D, Venugopal K, Ray S, Nair T, Rana DS, Kher V, Sawhney J, Kasliwal RR, Abdullakutty J, Chakraborty R, Chandra P, Bansal S, Kumar V, Pancholia AK, Kapoor A, Prakash S, Saxena A, Rastogi V, Sharma V, Arora YK, Dasbiswas A, Bhargava M, Jaswal A, Bhargava K, Bhatia M, Omar AK, Khanna NN, Passey R, Bhalla D, Vijayalakshmi IB, Bhalla AK, Moorthy A, Isser HS, Mishra SS, Routray S, Tandon V, Sinha A, Bansal M, Jain P, Hotchandani R, Jain D, Katyal VK, Gulati S, Tandon R, Jaggi S, Sehgal B, Gupta V, Mehrotra R, Krishnamani NC, Pathak SN, Yadav MS, Chawla R, Shastry NR, Chatterjee N, Samajdar SS, Pal J, Tiwaskar M. Chopra HK, et al. Among authors: abdullakutty j. J Assoc Physicians India. 2024 Jan;72(1):88-95. doi: 10.59556/japi.71.0400. J Assoc Physicians India. 2024. PMID: 38736080
Safety of the PCSK9 inhibitor alirocumab: insights from 47 296 patient-years of observation.
Goodman SG, Steg PG, Szarek M, Bhatt DL, Bittner VA, Diaz R, Harrington RA, Jukema JW, White HD, Zeiher AM, Manvelian G, Pordy R, Poulouin Y, Stipek W, Garon G, Schwartz GG; ODYSSEY OUTCOMES Investigators. Goodman SG, et al. Eur Heart J Cardiovasc Pharmacother. 2024 Jul 16;10(4):342-352. doi: 10.1093/ehjcvp/pvae025. Eur Heart J Cardiovasc Pharmacother. 2024. PMID: 38658193 Free PMC article. Review.
53 results